BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12072207)

  • 1. A new translocation that rearranges the AML1 gene in a patient with T-cell acute lymphoblastic leukemia.
    Mikhail FM; Serry KA; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Coignet L; Nucifora G
    Cancer Genet Cytogenet; 2002 May; 135(1):96-100. PubMed ID: 12072207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
    Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
    Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy.
    Roulston D; Espinosa R; Nucifora G; Larson RA; Le Beau MM; Rowley JD
    Blood; 1998 Oct; 92(8):2879-85. PubMed ID: 9763573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
    Zent C; Rowley JD; Nucifora G
    Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two new translocations that disrupt the AML1 gene.
    Richkind K; Hromas R; Lytle C; Crenshaw D; Velasco J; Roherty S; Srinivasiah J; Varella-Garcia M
    Cancer Genet Cytogenet; 2000 Oct; 122(2):141-3. PubMed ID: 11106827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
    Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
    Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia.
    Cherry AM; Bangs CD; Jones P; Hall S; Natkunam Y
    Cancer Genet Cytogenet; 2001 Sep; 129(2):155-60. PubMed ID: 11566347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New mechanisms of AML1 gene alteration in hematological malignancies.
    Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
    Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. t(8;21)(q22;q22) Translocation involving AML1 and ETO in B lymphoblastic leukemia [corrected].
    Wang HY; Tirado CA
    Hum Pathol; 2010 Feb; 41(2):286-92. PubMed ID: 19896694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AML1 interconnected pathways of leukemogenesis.
    Michaud J; Scott HS; Escher R
    Cancer Invest; 2003; 21(1):105-36. PubMed ID: 12643014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
    Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AML1 gene over-expression in childhood acute lymphoblastic leukemia.
    Mikhail FM; Serry KA; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Coignet L; Nucifora G
    Leukemia; 2002 Apr; 16(4):658-68. PubMed ID: 11960347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Runx1/AML1 in leukemia: disrupted association with diverse protein partners.
    Perry C; Eldor A; Soreq H
    Leuk Res; 2002 Mar; 26(3):221-8. PubMed ID: 11792409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
    de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
    Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2). a four-way variant of t(8;21).
    Vieira L; Oliveira V; Ambrósio AP; Marques B; Pereira AM; Hagemeijer A; Boavida MG
    Cancer Genet Cytogenet; 2001 Jul; 128(2):104-7. PubMed ID: 11463447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary acute myeloblastic leukemia with t(16;21) (q24;q22). involving the AML1 gene.
    Berger R; Le Coniat M; Romana SP; Jonveaux P
    Hematol Cell Ther; 1996 Apr; 38(2):183-6. PubMed ID: 8932000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel translocation, t(9;21)(q13;q22) rearranging the RUNX1 gene in acute myelomonocytic leukemia.
    Paulien S; Maarek O; Daniel MT; Berger R
    Ann Genet; 2002; 45(2):67-9. PubMed ID: 12119214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of genes involved in chronic myeloid leukemia with t (3; 21) (q26; q22) in blastic crisis].
    Liu XP; Zhang MR; Dai Y; Zhang L; Li R; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):310-3. PubMed ID: 16875579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.
    Zent CS; Mathieu C; Claxton DF; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1044-8. PubMed ID: 8577711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.